Global Clinical Trial Kits Market Product Research Report 2022

Posted by sandeep gade on December 22nd, 2022

  The global clinical trial kits market was valued at around US$ 1.3 Bn in 2021. With a projected CAGR of 12.3% for the next ten years; the market is likely to reach a valuation of US$ 4.6 Bn by the end of 2032. The increasing number of clinical trials performed globally is driving the clinical trial kits market.

Competitive Analysis

At present, clinical trial kit manufacturers are largely actively expanding their manufacturing facilities to boost production. The key companies operating in the clinical trial kits market include Azenta Life Sciences, Q2 Solutions, Patheon (Thermo fisher scientific), LabCorp drug development, Charles River Laboratories, LabConnect, Almac group, Precision medicine group, Cerba research, Alpha Laboratories Ltd, Marken SAS, and Clinigen.

Some of the recent developments by key providers of clinical trial kits are as follows:

Some of the recent developments of Clinical Trial Kits Market providers are as follows:

•          In May 2022, LabCorp drug development received emergency use authorization from FDA for the first Non-prescription At-Home collection Kit for combined Covid-19, Flu, and RSV detection.
•          In June 2021, UPS's healthcare Clinical trials unit of Marken announced a partnership with THREAD, a decentralized clinical trial technology provider, to create a unified decentralized trial solution in patients' homes. The partnership between Marken Home Healthcare and Clinical Trial Logistics Services provides a single workflow for patients and clients by having a partnership of Marken's Home Healthcare and Clinical Trial Logistics Services.
•          In June 2021 , Daxion Technologies and Q2 Solutions collaborated to develop a new blood test that will help patients to obtain their blood from any location. The new lab test, which works with Tasso's devices, will help patients collect their blood from anywhere.
•          In March 2021, LabConnect announced the expansion of its Johnson City facility to boost the manufacturing of clinical trial kits. The expansion includes the addition of 20,000 square feet to the facility, which will triple the kit building capacity.

Buy Full Report Now and Get Up to 20% Discount: https://www.persistencemarketresearch.com/checkout/33246